• Hematology / Oncology @Point of Care Podcasts

  • 著者： @Point of Care
  • ポッドキャスト

Hematology / Oncology @Point of Care Podcasts

著者： @Point of Care
無料で聴く

  • サマリー

  • Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
    Copyright 2020 At Point of Care, LLC. All rights reserved.
    続きを読む 一部表示

あらすじ・解説

Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
Copyright 2020 At Point of Care, LLC. All rights reserved.
身体的病い・疾患 衛生・健康的な生活
続きを読む 一部表示
エピソード
  • S21:E2 – Individualizing Care Plans for Patients With AML

    S21:E2 – Individualizing Care Plans for Patients With AML
    2024/09/30

    In this episode, Individualizing Care Plans for Patients With AML, Dr. Amer Zeidan and Dr. Guillermo Garcia-Manero discuss how to incorporate evidence-based treatment plans for patients with AML who are receiving oral HMA maintenance therapy. Who are the best candidates for these therapies?

    Visit https://suiteweb.atpointofcare.com/#library/mds-aml/2646.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    続きを読む 一部表示
    24 分
  • S21:E1 – Improving Survival With HMA Maintenance Therapy in AML

    S21:E1 – Improving Survival With HMA Maintenance Therapy in AML
    2024/09/30

    In this episode, Improving Survival With HMA Therapy in AML, Dr. Amer Zeidan and Dr. Guillermo Garcia-Manero discuss the latest clinical trial evidence for using hypomethylating agents as maintenance therapy for AML patients as well as which patients will benefit most from these therapies.

    Visit https://suiteweb.atpointofcare.com/#library/mds-aml/2646.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    続きを読む 一部表示
    42 分
  • S21:E3 – Identifying and Managing Treatment-Related Adverse Events (TRAEs) Associated With TROP2-Targeting Therapies

    S21:E3 – Identifying and Managing Treatment-Related Adverse Events (TRAEs) Associated With TROP2-Targeting Therapies
    2024/01/29

    In this episode, our faculty discuss the widespread expression of human epidermal growth factor receptor 3 (HER3) across tumor types and why clinicians should have HER3 on their radar. Visit https://suitehome.atpointofcare.com/library/2606.13/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    続きを読む 一部表示
    23 分

Hematology / Oncology @Point of Care Podcastsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。